Report: huge inequalities in access to myeloma clinical trials in Europe
Drug Discovery World
DECEMBER 6, 2022
Myeloma Patients Europe (MPE) has launched an advocacy report on addressing access barriers to myeloma clinical trials in Central and Eastern Europe (CEE). . The MPE report presents clinical trial analytics, looking at the number of clinical trials held in CEE countries between 1 January 2001 and 28 September 2020.
Let's personalize your content